Markus Weiss, who in this role is responsible for supporting the North American Business Units and Divisions has 18 years of experience in operationalizing strategy, preserving and growing value, scaling culture as well as business transformations. He is experienced in divisional, regional and country level leadership roles in technology, life science, manufacturing, construction and financial services.
With the opening of its state-of-the-art facility in Rockville in 2017, GSK has been strengthening its manufacturing presence in the US. As a result, the site’s portfolio of programs and bulk production has been growing steadily, with
The BioHealth Capital Region (BHCR) has been witnessing a strong upward growth trajectory in recent years. The COVID-19 pandemic has only heightened the need for increased research, diagnostic and domestic manufacturing needs in the region. But while workforce needs are in demand, the right skills are in short supply.
Novel Microdevices Joins Baltimore’s LaunchPort™ Medtech Venture Center Manufacturing Innovative Diagnostic Products for Enhancing Patient Healthcare BALTIMORE (PRWEB) FEBRUARY 26, 2021 The LaunchPort™ announced today that Novel Microdevices (http://www.noveldx.com) has moved [….]
Vigene, a gene therapy development company, said it intends to lease a 52,000 square-foot manufacturing space at 14200 Shady Grove Road that will nearly double the company’s existing manufacturing footprint. The new space is in addition to its existing headquarters, R&D, and manufacturing locations that opened in Rockville last year. The additional space from the new facility will allow the company to expand its current headcount of 125 by the addition of 245 more employees.
Rockville, Maryland’s Advanced BioScience Laboratories, Inc. (ABL) is a rapidly growing biotech company that provides expert contract manufacturing and laboratory research services to customers across the globe. The company delivers best-in-class GMP manufacturing and immunology solutions for gene therapies, oncolytics, vaccines, and other immunotherapeutics to life science organizations, and government agencies.
Kurt Elam joined ACC/Lab Owl in 2017 with 20+ years of specialty biopharmaceutical experience, focused primarily on oncology, infectious disease, and critical care/ICU medicine. He has overseen and managed the successful launch of over 16 new FDA approved products/compounds or new indications, and worked to gain formulary approval in managed care organizations, thereby improving access for patients.
CRB Wins 2019 ISPE Company of the Year Award at Annual Meeting – International Society of Pharmaceutical Engineers
This UMD Program is Providing Much Needed Biotechnology Industry Training to Meet Growing Demand January 8, 2019 The BREP program at UMD provides much-needed biotechnology industry training workshops that support [….]
Frederick Based Biosimilars Company begins GMP Manufacturing and Scales Headcount Image Credit: prweb.com/releases/2015/12/prweb13140953.htm BioFactura Inc. is a growing biotech company in Frederick, Maryland operating in an exciting and growing field. [….]
